Carglumic acid 200 mg/1
Carglumic acid · TABLET, FOR SUSPENSION · Navinta LLC
No Recall History
Plain English
Carglumic acid is a tablet, for suspension containing carglumic acid at 200 mg/1, taken oral. Manufactured by Navinta LLC.
Key Facts
- Brand Name
- Carglumic acid
- Generic Name
- Carglumic acid
- NDC Code (Product)
68475-006- Manufacturer
- Navinta LLC
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA213395
- Drug Class
- Carbamoyl Phosphate Synthetase 1 Activator [EPC]
- Marketing Start
- 08/01/2022
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
drug ineffective13 reports
vomiting13 reports
off label use7 reports
hyperammonaemia6 reports
hyperammonaemic encephalopathy6 reports
rebound effect6 reports
death5 reports
hospitalisation5 reports
tremor5 reports
abdominal discomfort4 reports
Frequently Asked Questions
What is Carglumic acid used for?
Carglumic acid contains Carglumic acid. It is a tablet, for suspension taken oral. Consult your doctor for specific uses.
Is Carglumic acid a controlled substance?
Carglumic acid is not classified as a controlled substance by the DEA.
What is the generic name for Carglumic acid?
The generic name for Carglumic acid is Carglumic acid. There are 2 other brand versions of Carglumic acid.
What is the NDC code for Carglumic acid 200 mg/1?
The NDC (National Drug Code) for Carglumic acid 200 mg/1 is 68475-006, listed by Navinta LLC.